August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden Continues Swiss Bank Investigation Following Indictment of American Credit Suisse Client on Tax Evasion Charges
- Wyden Urges Committee Approval of U.S. Tax Court Nominees
- Wyden Urges Senate Support for Tax Court Nominees
- Wyden, Senators Propose Criminal Penalties, Consumer Protections to Stop Rogue Health Insurance Brokers
- Wyden Statement on New Biden-Harris Administration Affordable Housing Initiative